Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Gaudette, CA

Frederic Gaudette, Verdun CA

Patent application numberDescriptionPublished
20090023734INHIBITORS OF HISTONE DEACETYLASE - The invention provides compounds and methods for treating cell proliferative diseases. The invention provides new inhibitors of histone deacetylase enzymatic activity, compositions of the compounds comprising the inhibitors and a pharmaceutically acceptable carrier, excipient, or diluent, and methods of using the compounds to inhibit cellular proliferation in vitro and therapeutically.01-22-2009
20100317625NOVEL SULFONAMIDOMETHYLPHOSPHONATE INHIBITORS OF BETA-LACTAMASE - This invention provides novel β-lactamase inhibitors of the aryl- and heteroaryl-sulfonamidomethylphosphonate monoester class. The compounds inhibit three classes of β-lactamases and synergize the antibacterial effects of β-lactam antibiotics (e.g., imipenem and ceftazimdime) against those micro-organisms normally resistant to the β-lactam antibiotics as a result of the presence of the β-lactamases.12-16-2010
20120083482INHIBITORS OF VEGF RECEPTOR AND HGF RECEPTOR SIGNALING - The invention relates to the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention provides compounds of general formula (A)04-05-2012

Patent applications by Frederic Gaudette, Verdun CA

Frederic Gaudette, Laval CA

Patent application numberDescriptionPublished
20080255155KINASE INHIBITORS AND USES THEREOF - This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds, compositions and methods for the inhibition of kinase activity. The invention also provides compounds, compositions and methods for treating cell proliferative diseases and conditions.10-16-2008
20090264440INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY - This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling and HGF receptor signaling. More particularly, the invention relates to compounds, compositions and methods for the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.10-22-2009
20100279983NOVEL INHIBITORS OF BETA-LACTAMASE - This invention provides novel β-lactamase inhibitors of the aryl- and heteroarylsulfonamidomethylphosphonate monoester class having nitrogen-based cations or quarternary ammonium groups. The compounds inhibit three classes of β-lactamases and synergize the antibacterial effects of β-lactam antibiotics (e.g., imipenem and ceftazidime) against those micro-organisms normally resistant to the β-lactam antibiotics as a result of the presence of the β-lactamases. Formula (I) or pharmaceutically acceptable salt thereof.11-04-2010

Patent applications by Frederic Gaudette, Laval CA

Frederic Gaudette, Sherbrooke CA

Patent application numberDescriptionPublished
20110077240INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY - This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling. The invention also provides compounds, compositions and methods for treating cell proliferative diseases and conditions and opthalmological diseases, disorders and conditions.03-31-2011
20110098293Inhibitors of Protein Tyrosine Kinase Activity - This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling. The invention also provides compounds, compositions and methods for treating cell proliferative diseases and conditions and opthalmological diseases, disorders and conditions.04-28-2011

Frédéric Gaudette, Laval CA

Patent application numberDescriptionPublished
20120108628INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY - This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling and HGF receptor signaling. More particularly, the invention relates to compounds, compositions and methods for the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.05-03-2012

Frédéric Gaudette, Sherbrooke CA

Patent application numberDescriptionPublished
20110077240INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY - This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling. The invention also provides compounds, compositions and methods for treating cell proliferative diseases and conditions and opthalmological diseases, disorders and conditions.03-31-2011
20110257100Inhibitors of Protein Tyrosine Kinase Activity - This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling. The invention also provides compounds, compositions and methods for treating cell proliferative diseases and conditions and ophthalmic diseases, disorders and conditions.10-20-2011
20110257175Selected Inhibitors of Protein Tyrosine Kinase Activity - The invention provides new compounds and compositions thereof. The invention also provides methods for treating ophthalmic diseases, disorders and conditions.10-20-2011

Jamie Gaudette, Pembroke CA

Patent application numberDescriptionPublished
20110188861REDUCING OPTICAL SERVICE CHANNEL INTERFERENCE IN PHASE MODULATED WAVELENGTH DIVISION MULTIPLEXED (WDM) COMMUNICATION SYSTEMS - A system for transmitting a plurality of data channels and an optical service channel through an optical fiber link of a Wavelength Division Multiplexed (WDM) optical communications system. The system comprises a first transmitter at a first end of the optical fiber link, for transmitting the data channels as a wavelength division multiplexed optical signal through the optical fiber link in a first direction. A second transmitter is connected at a second end of the optical fiber link, for transmitting the optical service channel through the optical fiber link in a second direction opposite to the first direction.08-04-2011

Jeffrey D. Gaudette, Windsor CA

Patent application numberDescriptionPublished
20090311065Apparatus, Systems and Methods for Securing Parts - A clip for securing a part, having a body portion having a first wall surface and a supporting surface adjacent the first wall surface, a retaining arm connected to the body, the retaining arm comprising a second wall surface opposite the first wall surface, an engaging portion at the distal end of the retaining arm, and an engaging surface on the engaging portion generally opposite the supporting surface. The first and second wall surfaces cooperate to define a groove that is sized and shaped to receive a portion of the part therein. The retaining arm is moveable between an open position wherein the portion of the part may be received in the groove, and a locked position wherein the engaging surface at least partially overhangs the groove and the engaging surface and the supporting surface cooperate so as to retain the portion of the part when received within the groove.12-17-2009